Related Articles
Targeting Bruton's tyrosine kinase signaling as an emerging therapeutic agent of B‑cell malignancies (Review)
Bruton's tyrosine kinase inhibitor restrains Wnt signaling in chronic lymphocytic leukemia
PDGFD induces ibrutinib resistance of diffuse large B‑cell lymphoma through activation of EGFR
Hodgkin's lymphoma as a rare variant of Richter's transformation in chronic lymphocytic leukemia: A case report and review of the literature
Challenges associated with the use of Bruton's tyrosine kinase inhibitors: A life‑saving therapy for chronic lymphocytic leukemia (Review)